Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:54:55 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:AYTU - AYTU BIOPHARMA INC - http://aytubio.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AYTU - Q0.92.60·3.180.12.9043+0.124.36.116502.90  2.92  2.883.50  1.3816:00:01Apr 0315 min RT 2¢

Recent Trades - Last 10 of 50
Time ETExPriceChangeVolume
16:00:01Q2.82-0.022
16:00:01Q2.82-0.022
15:58:42Q2.86580.02582
15:53:02Q2.815-0.0251
15:40:29Q2.79-0.0514
15:39:53Q2.7542-0.08586
14:52:35Q2.83-0.013
14:09:14Q2.91750.077530
14:09:14Q2.91750.077570
13:11:19Q2.920.084

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-03 09:04U:AYTUNews ReleaseAytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
2024-02-14 16:07U:AYTUNews ReleaseAytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
2024-02-07 16:17U:AYTUNews ReleaseAytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
2024-01-23 09:02U:AYTUNews ReleaseAytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
2023-11-14 16:17U:AYTUNews ReleaseAytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
2023-11-08 08:32U:AYTUNews ReleaseAytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
2023-11-07 16:17U:AYTUNews ReleaseAytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
2023-10-26 08:03U:AYTUNews ReleaseAytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
2023-10-09 16:17U:AYTUNews ReleaseAytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
2023-09-27 16:21U:AYTUNews ReleaseAytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
2023-09-21 20:26U:AYTUNews ReleaseAytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
2023-09-13 08:02U:AYTUNews ReleaseAytu BioPharma to Present at LD Micro Main Event XVI Conference
2023-08-08 09:16U:AYTUNews ReleaseStonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
2023-07-31 08:01U:AYTUNews ReleaseAytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
2023-07-10 08:01U:AYTUNews ReleaseAytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
2023-06-14 08:02U:AYTUNews ReleaseAytu to Participate in the Maxim Group Virtual Healthcare Conference
2023-06-13 13:46U:AYTUNews ReleaseAytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
2023-06-09 08:01U:AYTUNews ReleaseAytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
2023-05-11 16:06U:AYTUNews ReleaseAytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
2023-05-04 16:32U:AYTUNews ReleaseAytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023